Skip to main content

Table 2 Patient diagnoses, relapse status, and treatment status over time

From: Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis

Clinical and laboratory data Baseline 1 year 2 years 4 years
Number of subjects 41 41 40 39
Diagnosis (CIS/RRMS) 19/22 12/29 9/31 7/32
Relapse within last 2 months (yes/no) 23/18 4/37 2/38 2/37
Treatment (number of subjects)
 No DMT 41 17 18 18
 Interferon-β 1b 0 18 12 5
 Interferon-β 1a 0 1 1 1
 Dimetylfumarate 0 0 0 2
 Fingolimod 0 1 2 3
 Natalizumab 0 4 7 10